Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: Reversal of neuromuscular block in anaesthetized Rhesus monkeys

British Journal of Anaesthesia

Volumn 96, Issue 2, 2006, Pages 201-206

  de Boer, H D ^a   van Egmond, J ^a   van de Pol, F ^a   Bom, A ^b   Booij, L H D J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Pharmacology ^*  (United Kingdom)

Author keywords

Chemical encapsulation; Neuromuscular block, rocuronium; Reversal agent, cyclodextrins

Indexed keywords

ATROPINE; BETA CYCLODEXTRIN; CHEMICAL COMPOUND; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; GAMMA CYCLODEXTRIN DERIVATIVE; KETAMINE; NEOSTIGMINE; NITROUS OXIDE; OXYGEN; PENTOBARBITAL; ROCURONIUM;

ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BOLUS INJECTION; CHELATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG INFUSION; ENCAPSULATION; EXPERIMENTAL DESIGN; FEMALE; HEART RATE; MUSCLE EXCITATION; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; STEADY STATE;

EID: 31744446580     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aei306     Document Type: Article

References (11)

1. Hunter JM. New neuromuscular blocking drugs. N Engl J Med 1995; 332: 1691-9
2. Pedersen T, Viby-Mogensen J, Ringsted C. Anaesthetic practice and postoperative pulmonary complication. Acta Anaesthesiol Scand 1992; 36: 812-18
3. Shorten GD. Postoperative residual curarisation: Incidence, aetiology and associated morbidity. Anaesth Int Care 1993; 21: 782-9
4. Mencke T, Echternach M, Kleinschmidt S, et al. Laryngeal morbidity and quality of tracheal intubation: A randomized controlled trial. Anesthesiology 2003; 95: 1049-56
5. Viby-Mogensen J, Jørgensen BC, Ørding H. Residual curarization in the recovery room. Anesthesiology 1979; 50: 539-41
6. Booij LHDJ, De Boer HD, Van Egmond J. Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept. Sem Anesthesia Periop Med Pain 2002; 21: 92-8
7. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41: 266-270
8. Szejtli J. Medicinal applications of cyclodextrins. Med Res Rev 1994; 14: 353-86
9. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-103
10. Epemolu O, Mayer I, Hope F, Scullion P, Desmond P. Liquid chromatography/ mass spectrometric bioanalysis of a modified γ cyclodextrin (Org 25969) and rocuronium bromide (Org 9426) in guinea pig plasma and urine: Its application to determine the plasma pharmacokinetics of Org 25969. Rapid Commun Mass Spectrom 2002; 16: 1946-52
11. Van Egmond J, van de Pol F, Booij L, et al. Neuromuscular blockade induced by steroidal NMBs can be rapidly reversed by Org 25969 in the anaesthetised monkey. Eur J Anaesthesiol 2001; 18: A100